Israel Active

Israel’s Montfort (Mon4t – see previously) is expanding the operation of its brain monitor device in the US. It is already in use at Baltimore’s John Hopkins Medicine and the Henry Ford Health System in Detroit. It could benefit the million and more Parkinson’s sufferers in the US.

Several Israeli health-tech startups have applied to participate in the Wellness Tech Bootcamp, an international program supporting startups developing technologies to improve physical and mental health. New to this newsletter include Happy Things, CoBe Labs, and Kai (personal wellness coach)

Israel’s Healthy.io (see previously) has been authorized to deploy its smartphone image diagnostic technology in the United Arab Emirates. It has finalized a deal with Dubai’s Royal family-founded Seed Group, to sell its self-performed kidney disease urine analysis kits in the UAE.

Researchers from Ben Gurion University have shown that routine prenatal ultrasound in the second trimester can identify early signs of autism spectrum disorder (ASD). Anomalies occurred in 30% of fetuses who later developed ASD. It means autism could be treated from birth.

Israel’s HIL Applied Medical (see previously) is poised to deliver proton-beam radiotherapy to millions of cancer patients who cannot afford it today. HIL plans to produce 200-250 much lower cost proton therapy rooms every year.

Phase 3 clinical trials confirmed that the Nitric Oxide Nasal Spray (NONS) from Israel’s SaNOtize represents a safe and effective antiviral treatment that shortens the course of COVID-19 and could prevent the transmission of COVID-19. It also received regulatory approval in India.

Tel Aviv University scientists have identified pathological activity in the brain that precedes initial Alzheimer’s symptoms by many years. A systemic failure causes high activity in the hippocampus even during sleep. They also found that an existing MS treatment suppresses this activity.

A first-of-its-kind 3D-printed spinal cord tissue implant developed in Prof. Tal Dvir’s regenerative biotechnology lab at Tel Aviv University, has enabled paralyzed lab mice to walk again. Startup Matricelf (see previously) is now working on a human version.

Dr. Daphne Haim-Langford was just 16 when a doctor told her not to study as she was going blind with Uveitis. It pushed her to get a PhD at Israel’s Technion Institute, found medical startup Tarsier and win the EU 2021 prize for female innovators (see previously).

Do you know of someone interested in pursuing their M.D. or MBA degree in Israel? This video features Lynne M. Quittell, M.D., director of the North American office of BGU’s Medical School for International Health.